Literature DB >> 3107375

Pregnancy in lupus nephritis and related disorders.

G Bobrie, F Liote, P Houillier, J P Grünfeld, P Jungers.   

Abstract

We studied retrospectively the influence of lupus nephropathy on the outcome of pregnancy and of pregnancy on the course of lupus nephritis in 213 pregnancies observed from 1962 to 1985 in a series of 73 patients with systemic lupus erythematosus (SLE). Renal biopsy demonstrated diffuse or focal proliferative glomerular lesions in 48 of 66 patients. The overall incidence of live births was 162 in 213 (76%). Fetal death rate, corrected for induced abortions, was markedly higher when SLE first manifested during or immediately after the index gestation (five of 11, or 45%) than in pregnancies that began prior to clinical onset of SLE (16 of 140, or 11.4%) and in those occurring after onset of SLE (five of 38, or 13.1%). Relapse or an exacerbation of SLE activity occurred in 18 (34%) of 53 pregnancies (in 35 women) which took place after the clinical onset of the disease. Such complications were more frequent (16 of 26 cases, or 61%) in pregnancies in which SLE was clinically active at conception as compared with gestations in which SLE was in clinical remission prior to conception (two of 27 cases, or 7%). There were six instances of severe renal "flare-up," four of which progressed to end-stage renal failure (ESRF) within a few years, including one instance in a patient who was in remission before conception. We conclude that successful outcome of pregnancy without deterioration of maternal renal function may most often be obtained even in previously severe forms of SLE, provided gestation is started in a period of sustained therapeutic remission.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107375     DOI: 10.1016/s0272-6386(87)80133-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

Review 1.  Lupus and pregnancy: complex yet manageable.

Authors:  Josephine Patricia Dhar; Robert J Sokol
Journal:  Clin Med Res       Date:  2006-12

2.  Oesophageal anomaly in a newborn after maternal exposure to mycofenolate mofetil.

Authors:  Subash Somalanka; Mohamed Tawil; Shashidhar Baikunje
Journal:  BMJ Case Rep       Date:  2009-09-02

Review 3.  Pregnancy in systemic lupus erythematosus.

Authors:  C C Mok; R W Wong
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

4.  Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?

Authors:  Jinoos Yazdany; Laura Trupin; Rachel Kaiser; Gabriela Schmajuk; Joann Zell Gillis; Eliza Chakravarty; Eleanor Bimla Schwarz
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-11-15       Impact factor: 4.794

5.  Active disease during pregnancy is associated with poor foetal outcome in Indian patients with systemic lupus erythematosus.

Authors:  Vinod Chandran; Amita Aggarwal; Ramnath Misra
Journal:  Rheumatol Int       Date:  2004-12-31       Impact factor: 2.631

Review 6.  Preconception care: screening and management of chronic disease and promoting psychological health.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

7.  Pregnancy in Women With Preexisting Glomerular Diseases: A Single-Center Experience.

Authors:  Smaragdi Marinaki; Stathis Tsiakas; Chrysanthi Skalioti; Eleni Kapsia; Sophia Lionaki; Kalliopi Vallianou; John Boletis
Journal:  Front Med (Lausanne)       Date:  2022-02-14

8.  Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review.

Authors:  Sai Yan Yuen; Adriana Krizova; Janine M Ouimet; Janet E Pope
Journal:  Open Rheumatol J       Date:  2008-12-31

9.  The role of lupus nephritis in development of adverse maternal and fetal outcomes during pregnancy.

Authors:  Alimohammad Fatemi; Reyhaneh Motamedi Fard; Zahra Sayedbonakdar; Ziba Farajzadegan; Mina Saber
Journal:  Int J Prev Med       Date:  2013-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.